[13] In Achilles transection and quadriceps reattachment models, significantly improved tensile strength and biomechanical outcomes
121,134 GIP, another insulin secretion agonist, helps release insulin, particularly after eating, enhancing the effects of GLP-1 and thereby improving the overall therapeutic efficacy of the drug
Key points Most muscle cramps are uncomfortable but not dangerous Seek medical attention for severe, persistent cramps that interfere with daily activities Watch for warning signs like significant weakness, irregular heartbeat, or confusion Dosage adjustments may help if cramping is severe or persistent Comparison with other medications While specific data on muscle cramp frequency across GLP-1 medications is limited, we can compare the broader category of musculoskeletal side effects from clinical trials and post-marketing data
Important safety information Prescribed GLP-1 medication, reviewed by a licensed provider and shipped to your door
Hallmarks of aging: The trial reported improvements across seven of the nine recognized hallmarks of aging, including markers of mitochondrial dysfunction, genomic damage, cellular senescence, and stem cell exhaustion
